Herbal medicines represent a pharmacologically diverse class of therapeutics that have gained renewed scientific interest as potential alternatives or adjuncts to conventional synthetic drugs. Unlike traditional ethnopharmacological narratives, contemporary research emphasizes evidence-based characterization of bioactive phytochemicals, elucidation of molecular mechanisms, and rigorous clinical validation. This review critically examines the pharmacological basis, therapeutic applications, and translational challenges of herbal medicines within the framework of modern pharmaceutical sciences. Key herbal drug classes including cardiovascular agents, anti-inflammatory compounds, neuroprotective phytochemicals, and antimicrobial botanicals are analyzed with emphasis on their pharmacodynamic properties, target engagement, and mechanistic pathways. Comparative assessment reveals that certain standardized herbal preparations demonstrate efficacy profiles comparable to synthetic drugs while potentially offering advantages in multi-target modulation, synergistic effects, and tolerability. However, significant challenges persist regarding standardization, pharmacokinetic variability, drug-herb interactions, regulatory classification, and the paucity of robust head-to-head clinical trials. The translational pathway from traditional use to evidence-based medicine requires integration of advanced analytical techniques, pharmacokinetic modeling, systems pharmacology approaches, and adherence to stringent regulatory frameworks. This review synthesizes current scientific evidence supporting herbal medicines as viable therapeutic alternatives, identifies critical knowledge gaps, and proposes strategies for their rational integration into contemporary clinical practice.